Ísrael - hebreska - Ministry of Health

medoc ltd, advanced medical systems - כלל האוכלוסיה - מתן חמצן למקרה חירום ..

Ísrael - hebreska - Ministry of Health

שילה חדשנות רפואית בע"מ - רופא - מערכות למשיכת גופים זרים ,אבנים וקטטרים ,סטנטים פריפריים-סטנט יופלקס בעל מערכת שיחרור עצמית לטיפול בכלי דם פריפריים ואנדרסטנט לכיסוי דליפות וקרעים בכלי דם פריפריים-כל הגדלים

Ísrael - hebreska - Ministry of Health

נובוגולד בע"מ - רופא - משתלי סיליקון ונילווים

Ísrael - hebreska - Ministry of Health

teva israel ltd - bisacodyl - טבליות מצופות פילם - bisacodyl 5 mg - bisacodyl - bisacodyl - all types of constipation in ambulatory and bedridden in patients over the age of 6 years . preparation of patients for abdominal radiography and proctoscopy.

Ísrael - hebreska - Ministry of Health

cts chemical industries ltd, israel - bisacodyl - טבליות עם ציפוי אנטרי - bisacodyl 5 mg - bisacodyl - bisacodyl - all types of constipation in ambulatory and bedridden patients over the age of 6 years. preparation of patients for abdominal radiography and proctoscopy.

Ísrael - hebreska - Ministry of Health

rafa laboratories ltd - biperiden hydrochloride - טבליה - biperiden hydrochloride 2 mg - biperiden - biperiden - all types of parkinson's disease.

Ísrael - hebreska - Ministry of Health

novartis israel ltd - fludarabine phosphate - תרכיז להכנת תמיסה לאינפוזיה\הזרקה - fludarabine phosphate 50 mg/dose - fludarabine - fludarabine - palliative treatment of patients with cll refractory to other therapy. treatment of less malignant non-hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. fludarabine is indicated for the initial treatment of patients with b- cell chronic lymphocytic leukaemia (cll) or after first line therapy, in patients with sufficient bone marrow reserves.

Ísrael - hebreska - Ministry of Health

tzamal bio-pharma ltd - metformin hydrochloride; pioglitazone as hydrochloride - טבליות מצופות פילם - metformin hydrochloride 850 mg; pioglitazone as hydrochloride 15 mg - metformin - metformin - competact is indicated as second line treatment of type 2 diabetes mellitus adult patients,particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.after initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in hba1c). in patients who fail to show an adequate response, pioglitazone should be discontinued. in light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained.

Ísrael - hebreska - Ministry of Health

sanofi israel ltd - clopidogrel as hydrogen sulfate - טבליות מצופות פילם - clopidogrel as hydrogen sulfate 75 mg - clopidogrel - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid

Ísrael - hebreska - Ministry of Health

teva israel ltd - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or